Technology contributor, a spinoff from Centre for Virology, Vaccine and Therapeutics(InnoHK), has a vaccine platform that has completed proof of concept for influenza and COVID -19. Antigen of any highly contagious virus can be inserted into this platform to make a new vaccine within 3 weeks, the process is cell-based using attenuated virus technology and require containment.